Tag

Healthcare Communications

The Mylan EpiPen Pricing Crisis: A Pharmaceutical Communications Case Study

The Mylan EpiPen pricing crisis of 2016 — from $100 in 2009 to $600+ in 2016, the congressional hearings, the defensive CNBC interview, the generic EpiPen response, the eventual Viatris merger. Four enduring lessons for pharmaceutical crisis communications.

EPR Editorial Team · Sep 13, 2016

PR News

The Johnson & Johnson Tylenol Recall Era: A Crisis Communications Reference

EPR's reference on the 2009-2011 Johnson & Johnson Tylenol recall cycle — more than 288 million units across 50+ recalls. The modern companion case study to the famous 1982 Tylenol cyanide crisis masterclass, with the contrast between the two response operations.

EPR Editorial Team · Oct 19, 2010